nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinoxacin—Anorexia—Temsirolimus—kidney cancer	0.00665	0.00665	CcSEcCtD
Cinoxacin—Oedema—Pazopanib—kidney cancer	0.00657	0.00657	CcSEcCtD
Cinoxacin—Thrombocytopenia—Pazopanib—kidney cancer	0.00643	0.00643	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00637	0.00637	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Gemcitabine—kidney cancer	0.00637	0.00637	CcSEcCtD
Cinoxacin—Insomnia—Temsirolimus—kidney cancer	0.00631	0.00631	CcSEcCtD
Cinoxacin—Anorexia—Pazopanib—kidney cancer	0.00626	0.00626	CcSEcCtD
Cinoxacin—Somnolence—Temsirolimus—kidney cancer	0.0062	0.0062	CcSEcCtD
Cinoxacin—Decreased appetite—Temsirolimus—kidney cancer	0.00606	0.00606	CcSEcCtD
Cinoxacin—Erythema multiforme—Sorafenib—kidney cancer	0.00599	0.00599	CcSEcCtD
Cinoxacin—Pain—Temsirolimus—kidney cancer	0.00596	0.00596	CcSEcCtD
Cinoxacin—Insomnia—Pazopanib—kidney cancer	0.00594	0.00594	CcSEcCtD
Cinoxacin—Tinnitus—Sorafenib—kidney cancer	0.00591	0.00591	CcSEcCtD
Cinoxacin—Paraesthesia—Pazopanib—kidney cancer	0.0059	0.0059	CcSEcCtD
Cinoxacin—Somnolence—Pazopanib—kidney cancer	0.00584	0.00584	CcSEcCtD
Cinoxacin—Angioedema—Everolimus—kidney cancer	0.00581	0.00581	CcSEcCtD
Cinoxacin—Erythema multiforme—Sunitinib—kidney cancer	0.00576	0.00576	CcSEcCtD
Cinoxacin—Decreased appetite—Pazopanib—kidney cancer	0.00571	0.00571	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Temsirolimus—kidney cancer	0.0057	0.0057	CcSEcCtD
Cinoxacin—Pain—Pazopanib—kidney cancer	0.00562	0.00562	CcSEcCtD
Cinoxacin—Abdominal pain—Temsirolimus—kidney cancer	0.00551	0.00551	CcSEcCtD
Cinoxacin—Erythema multiforme—Dactinomycin—kidney cancer	0.00546	0.00546	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.0054	0.0054	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Pazopanib—kidney cancer	0.00537	0.00537	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00533	0.00533	CcSEcCtD
Cinoxacin—Abdominal pain—Pazopanib—kidney cancer	0.00519	0.00519	CcSEcCtD
Cinoxacin—Oedema—Everolimus—kidney cancer	0.00519	0.00519	CcSEcCtD
Cinoxacin—Hypersensitivity—Temsirolimus—kidney cancer	0.00514	0.00514	CcSEcCtD
Cinoxacin—Thrombocytopenia—Vinblastine—kidney cancer	0.0051	0.0051	CcSEcCtD
Cinoxacin—Thrombocytopenia—Everolimus—kidney cancer	0.00508	0.00508	CcSEcCtD
Cinoxacin—Angioedema—Sorafenib—kidney cancer	0.00504	0.00504	CcSEcCtD
Cinoxacin—Oedema—Erlotinib—kidney cancer	0.005	0.005	CcSEcCtD
Cinoxacin—Anorexia—Vinblastine—kidney cancer	0.00496	0.00496	CcSEcCtD
Cinoxacin—Anorexia—Everolimus—kidney cancer	0.00494	0.00494	CcSEcCtD
Cinoxacin—Pruritus—Temsirolimus—kidney cancer	0.00493	0.00493	CcSEcCtD
Cinoxacin—Thrombocytopenia—Erlotinib—kidney cancer	0.0049	0.0049	CcSEcCtD
Cinoxacin—Angioedema—Sunitinib—kidney cancer	0.00485	0.00485	CcSEcCtD
Cinoxacin—Diarrhoea—Temsirolimus—kidney cancer	0.00477	0.00477	CcSEcCtD
Cinoxacin—Anorexia—Erlotinib—kidney cancer	0.00477	0.00477	CcSEcCtD
Cinoxacin—Insomnia—Everolimus—kidney cancer	0.00469	0.00469	CcSEcCtD
Cinoxacin—Paraesthesia—Vinblastine—kidney cancer	0.00467	0.00467	CcSEcCtD
Cinoxacin—Paraesthesia—Everolimus—kidney cancer	0.00466	0.00466	CcSEcCtD
Cinoxacin—Pruritus—Pazopanib—kidney cancer	0.00465	0.00465	CcSEcCtD
Cinoxacin—Erythema multiforme—Gemcitabine—kidney cancer	0.00463	0.00463	CcSEcCtD
Cinoxacin—Somnolence—Everolimus—kidney cancer	0.00461	0.00461	CcSEcCtD
Cinoxacin—Dizziness—Temsirolimus—kidney cancer	0.00461	0.00461	CcSEcCtD
Cinoxacin—Insomnia—Erlotinib—kidney cancer	0.00453	0.00453	CcSEcCtD
Cinoxacin—Decreased appetite—Vinblastine—kidney cancer	0.00453	0.00453	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00452	0.00452	CcSEcCtD
Cinoxacin—Decreased appetite—Everolimus—kidney cancer	0.00451	0.00451	CcSEcCtD
Cinoxacin—Anaphylactic shock—Sorafenib—kidney cancer	0.0045	0.0045	CcSEcCtD
Cinoxacin—Diarrhoea—Pazopanib—kidney cancer	0.00449	0.00449	CcSEcCtD
Cinoxacin—Pain—Vinblastine—kidney cancer	0.00445	0.00445	CcSEcCtD
Cinoxacin—Pain—Everolimus—kidney cancer	0.00443	0.00443	CcSEcCtD
Cinoxacin—Vomiting—Temsirolimus—kidney cancer	0.00443	0.00443	CcSEcCtD
Cinoxacin—Thrombocytopenia—Sorafenib—kidney cancer	0.00441	0.00441	CcSEcCtD
Cinoxacin—Rash—Temsirolimus—kidney cancer	0.0044	0.0044	CcSEcCtD
Cinoxacin—Dermatitis—Temsirolimus—kidney cancer	0.00439	0.00439	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00437	0.00437	CcSEcCtD
Cinoxacin—Headache—Temsirolimus—kidney cancer	0.00437	0.00437	CcSEcCtD
Cinoxacin—Decreased appetite—Erlotinib—kidney cancer	0.00435	0.00435	CcSEcCtD
Cinoxacin—Dizziness—Pazopanib—kidney cancer	0.00434	0.00434	CcSEcCtD
Cinoxacin—Oedema—Sunitinib—kidney cancer	0.00433	0.00433	CcSEcCtD
Cinoxacin—Anorexia—Sorafenib—kidney cancer	0.00429	0.00429	CcSEcCtD
Cinoxacin—Pain—Erlotinib—kidney cancer	0.00428	0.00428	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Vinblastine—kidney cancer	0.00426	0.00426	CcSEcCtD
Cinoxacin—Thrombocytopenia—Sunitinib—kidney cancer	0.00424	0.00424	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Everolimus—kidney cancer	0.00424	0.00424	CcSEcCtD
Cinoxacin—Vomiting—Pazopanib—kidney cancer	0.00418	0.00418	CcSEcCtD
Cinoxacin—Rash—Pazopanib—kidney cancer	0.00414	0.00414	CcSEcCtD
Cinoxacin—Nausea—Temsirolimus—kidney cancer	0.00414	0.00414	CcSEcCtD
Cinoxacin—Dermatitis—Pazopanib—kidney cancer	0.00414	0.00414	CcSEcCtD
Cinoxacin—Anorexia—Sunitinib—kidney cancer	0.00413	0.00413	CcSEcCtD
Cinoxacin—Abdominal pain—Vinblastine—kidney cancer	0.00412	0.00412	CcSEcCtD
Cinoxacin—Headache—Pazopanib—kidney cancer	0.00411	0.00411	CcSEcCtD
Cinoxacin—Oedema—Dactinomycin—kidney cancer	0.0041	0.0041	CcSEcCtD
Cinoxacin—Abdominal pain—Everolimus—kidney cancer	0.0041	0.0041	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Erlotinib—kidney cancer	0.00409	0.00409	CcSEcCtD
Cinoxacin—Thrombocytopenia—Dactinomycin—kidney cancer	0.00401	0.00401	CcSEcCtD
Cinoxacin—Abdominal pain—Erlotinib—kidney cancer	0.00396	0.00396	CcSEcCtD
Cinoxacin—Insomnia—Sunitinib—kidney cancer	0.00392	0.00392	CcSEcCtD
Cinoxacin—Decreased appetite—Sorafenib—kidney cancer	0.00391	0.00391	CcSEcCtD
Cinoxacin—Anorexia—Dactinomycin—kidney cancer	0.00391	0.00391	CcSEcCtD
Cinoxacin—Nausea—Pazopanib—kidney cancer	0.0039	0.0039	CcSEcCtD
Cinoxacin—Paraesthesia—Sunitinib—kidney cancer	0.00389	0.00389	CcSEcCtD
Cinoxacin—Erythema multiforme—Paclitaxel—kidney cancer	0.00387	0.00387	CcSEcCtD
Cinoxacin—Pain—Sorafenib—kidney cancer	0.00385	0.00385	CcSEcCtD
Cinoxacin—Hypersensitivity—Vinblastine—kidney cancer	0.00384	0.00384	CcSEcCtD
Cinoxacin—Hypersensitivity—Everolimus—kidney cancer	0.00382	0.00382	CcSEcCtD
Cinoxacin—Tinnitus—Paclitaxel—kidney cancer	0.00382	0.00382	CcSEcCtD
Cinoxacin—Decreased appetite—Sunitinib—kidney cancer	0.00377	0.00377	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00371	0.00371	CcSEcCtD
Cinoxacin—Pain—Sunitinib—kidney cancer	0.0037	0.0037	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Sorafenib—kidney cancer	0.00368	0.00368	CcSEcCtD
Cinoxacin—Pruritus—Everolimus—kidney cancer	0.00367	0.00367	CcSEcCtD
Cinoxacin—Anaphylactic shock—Vincristine—kidney cancer	0.00366	0.00366	CcSEcCtD
Cinoxacin—Oedema—Vincristine—kidney cancer	0.00366	0.00366	CcSEcCtD
Cinoxacin—Thrombocytopenia—Vincristine—kidney cancer	0.00359	0.00359	CcSEcCtD
Cinoxacin—Urticaria—Sorafenib—kidney cancer	0.00358	0.00358	CcSEcCtD
Cinoxacin—Decreased appetite—Dactinomycin—kidney cancer	0.00356	0.00356	CcSEcCtD
Cinoxacin—Diarrhoea—Vinblastine—kidney cancer	0.00356	0.00356	CcSEcCtD
Cinoxacin—Abdominal pain—Sorafenib—kidney cancer	0.00356	0.00356	CcSEcCtD
Cinoxacin—Diarrhoea—Everolimus—kidney cancer	0.00355	0.00355	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Sunitinib—kidney cancer	0.00354	0.00354	CcSEcCtD
Cinoxacin—Pruritus—Erlotinib—kidney cancer	0.00354	0.00354	CcSEcCtD
Cinoxacin—Pain—Dactinomycin—kidney cancer	0.00351	0.00351	CcSEcCtD
Cinoxacin—Anorexia—Vincristine—kidney cancer	0.00349	0.00349	CcSEcCtD
Cinoxacin—Anaphylactic shock—Gemcitabine—kidney cancer	0.00348	0.00348	CcSEcCtD
Cinoxacin—Oedema—Gemcitabine—kidney cancer	0.00348	0.00348	CcSEcCtD
Cinoxacin—Dizziness—Vinblastine—kidney cancer	0.00344	0.00344	CcSEcCtD
Cinoxacin—Dizziness—Everolimus—kidney cancer	0.00343	0.00343	CcSEcCtD
Cinoxacin—Abdominal pain—Sunitinib—kidney cancer	0.00342	0.00342	CcSEcCtD
Cinoxacin—Diarrhoea—Erlotinib—kidney cancer	0.00342	0.00342	CcSEcCtD
Cinoxacin—Thrombocytopenia—Gemcitabine—kidney cancer	0.0034	0.0034	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00335	0.00335	CcSEcCtD
Cinoxacin—Hypersensitivity—Sorafenib—kidney cancer	0.00332	0.00332	CcSEcCtD
Cinoxacin—Insomnia—Vincristine—kidney cancer	0.00331	0.00331	CcSEcCtD
Cinoxacin—Anorexia—Gemcitabine—kidney cancer	0.00331	0.00331	CcSEcCtD
Cinoxacin—Vomiting—Vinblastine—kidney cancer	0.00331	0.00331	CcSEcCtD
Cinoxacin—Dizziness—Erlotinib—kidney cancer	0.00331	0.00331	CcSEcCtD
Cinoxacin—Vomiting—Everolimus—kidney cancer	0.0033	0.0033	CcSEcCtD
Cinoxacin—Paraesthesia—Vincristine—kidney cancer	0.00329	0.00329	CcSEcCtD
Cinoxacin—Rash—Everolimus—kidney cancer	0.00327	0.00327	CcSEcCtD
Cinoxacin—Dermatitis—Everolimus—kidney cancer	0.00327	0.00327	CcSEcCtD
Cinoxacin—Headache—Vinblastine—kidney cancer	0.00326	0.00326	CcSEcCtD
Cinoxacin—Angioedema—Paclitaxel—kidney cancer	0.00326	0.00326	CcSEcCtD
Cinoxacin—Headache—Everolimus—kidney cancer	0.00325	0.00325	CcSEcCtD
Cinoxacin—Abdominal pain—Dactinomycin—kidney cancer	0.00324	0.00324	CcSEcCtD
Cinoxacin—Hypersensitivity—Sunitinib—kidney cancer	0.00319	0.00319	CcSEcCtD
Cinoxacin—Decreased appetite—Vincristine—kidney cancer	0.00318	0.00318	CcSEcCtD
Cinoxacin—Pruritus—Sorafenib—kidney cancer	0.00318	0.00318	CcSEcCtD
Cinoxacin—Vomiting—Erlotinib—kidney cancer	0.00318	0.00318	CcSEcCtD
Cinoxacin—Erythema multiforme—Capecitabine—kidney cancer	0.00318	0.00318	CcSEcCtD
Cinoxacin—Rash—Erlotinib—kidney cancer	0.00315	0.00315	CcSEcCtD
Cinoxacin—Dermatitis—Erlotinib—kidney cancer	0.00315	0.00315	CcSEcCtD
Cinoxacin—Insomnia—Gemcitabine—kidney cancer	0.00314	0.00314	CcSEcCtD
Cinoxacin—Headache—Erlotinib—kidney cancer	0.00313	0.00313	CcSEcCtD
Cinoxacin—Tinnitus—Capecitabine—kidney cancer	0.00313	0.00313	CcSEcCtD
Cinoxacin—Pain—Vincristine—kidney cancer	0.00313	0.00313	CcSEcCtD
Cinoxacin—Paraesthesia—Gemcitabine—kidney cancer	0.00312	0.00312	CcSEcCtD
Cinoxacin—Nausea—Vinblastine—kidney cancer	0.00309	0.00309	CcSEcCtD
Cinoxacin—Somnolence—Gemcitabine—kidney cancer	0.00309	0.00309	CcSEcCtD
Cinoxacin—Nausea—Everolimus—kidney cancer	0.00308	0.00308	CcSEcCtD
Cinoxacin—Diarrhoea—Sorafenib—kidney cancer	0.00308	0.00308	CcSEcCtD
Cinoxacin—Pruritus—Sunitinib—kidney cancer	0.00306	0.00306	CcSEcCtD
Cinoxacin—Decreased appetite—Gemcitabine—kidney cancer	0.00302	0.00302	CcSEcCtD
Cinoxacin—Hypersensitivity—Dactinomycin—kidney cancer	0.00302	0.00302	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Vincristine—kidney cancer	0.003	0.003	CcSEcCtD
Cinoxacin—Dizziness—Sorafenib—kidney cancer	0.00298	0.00298	CcSEcCtD
Cinoxacin—Pain—Gemcitabine—kidney cancer	0.00297	0.00297	CcSEcCtD
Cinoxacin—Nausea—Erlotinib—kidney cancer	0.00297	0.00297	CcSEcCtD
Cinoxacin—Diarrhoea—Sunitinib—kidney cancer	0.00296	0.00296	CcSEcCtD
Cinoxacin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00291	0.00291	CcSEcCtD
Cinoxacin—Oedema—Paclitaxel—kidney cancer	0.00291	0.00291	CcSEcCtD
Cinoxacin—Abdominal pain—Vincristine—kidney cancer	0.0029	0.0029	CcSEcCtD
Cinoxacin—Dizziness—Sunitinib—kidney cancer	0.00286	0.00286	CcSEcCtD
Cinoxacin—Vomiting—Sorafenib—kidney cancer	0.00286	0.00286	CcSEcCtD
Cinoxacin—Thrombocytopenia—Paclitaxel—kidney cancer	0.00285	0.00285	CcSEcCtD
Cinoxacin—Rash—Sorafenib—kidney cancer	0.00284	0.00284	CcSEcCtD
Cinoxacin—Dermatitis—Sorafenib—kidney cancer	0.00284	0.00284	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00282	0.00282	CcSEcCtD
Cinoxacin—Headache—Sorafenib—kidney cancer	0.00282	0.00282	CcSEcCtD
Cinoxacin—Diarrhoea—Dactinomycin—kidney cancer	0.00281	0.00281	CcSEcCtD
Cinoxacin—Anorexia—Paclitaxel—kidney cancer	0.00277	0.00277	CcSEcCtD
Cinoxacin—Vomiting—Sunitinib—kidney cancer	0.00275	0.00275	CcSEcCtD
Cinoxacin—Rash—Sunitinib—kidney cancer	0.00273	0.00273	CcSEcCtD
Cinoxacin—Dermatitis—Sunitinib—kidney cancer	0.00273	0.00273	CcSEcCtD
Cinoxacin—Headache—Sunitinib—kidney cancer	0.00271	0.00271	CcSEcCtD
Cinoxacin—Hypersensitivity—Vincristine—kidney cancer	0.0027	0.0027	CcSEcCtD
Cinoxacin—Eosinophilia—Doxorubicin—kidney cancer	0.00268	0.00268	CcSEcCtD
Cinoxacin—Nausea—Sorafenib—kidney cancer	0.00267	0.00267	CcSEcCtD
Cinoxacin—Insomnia—Paclitaxel—kidney cancer	0.00263	0.00263	CcSEcCtD
Cinoxacin—Paraesthesia—Paclitaxel—kidney cancer	0.00261	0.00261	CcSEcCtD
Cinoxacin—Vomiting—Dactinomycin—kidney cancer	0.00261	0.00261	CcSEcCtD
Cinoxacin—Somnolence—Paclitaxel—kidney cancer	0.00259	0.00259	CcSEcCtD
Cinoxacin—Rash—Dactinomycin—kidney cancer	0.00259	0.00259	CcSEcCtD
Cinoxacin—Nausea—Sunitinib—kidney cancer	0.00257	0.00257	CcSEcCtD
Cinoxacin—Decreased appetite—Paclitaxel—kidney cancer	0.00253	0.00253	CcSEcCtD
Cinoxacin—Diarrhoea—Vincristine—kidney cancer	0.00251	0.00251	CcSEcCtD
Cinoxacin—Pain—Paclitaxel—kidney cancer	0.00249	0.00249	CcSEcCtD
Cinoxacin—Pruritus—Gemcitabine—kidney cancer	0.00246	0.00246	CcSEcCtD
Cinoxacin—Nausea—Dactinomycin—kidney cancer	0.00244	0.00244	CcSEcCtD
Cinoxacin—Dizziness—Vincristine—kidney cancer	0.00242	0.00242	CcSEcCtD
Cinoxacin—Drowsiness—Doxorubicin—kidney cancer	0.00241	0.00241	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00239	0.00239	CcSEcCtD
Cinoxacin—Oedema—Capecitabine—kidney cancer	0.00239	0.00239	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00238	0.00238	CcSEcCtD
Cinoxacin—Diarrhoea—Gemcitabine—kidney cancer	0.00238	0.00238	CcSEcCtD
Cinoxacin—Thrombocytopenia—Capecitabine—kidney cancer	0.00234	0.00234	CcSEcCtD
Cinoxacin—Vomiting—Vincristine—kidney cancer	0.00233	0.00233	CcSEcCtD
Cinoxacin—Urticaria—Paclitaxel—kidney cancer	0.00231	0.00231	CcSEcCtD
Cinoxacin—Rash—Vincristine—kidney cancer	0.00231	0.00231	CcSEcCtD
Cinoxacin—Dermatitis—Vincristine—kidney cancer	0.00231	0.00231	CcSEcCtD
Cinoxacin—Abdominal pain—Paclitaxel—kidney cancer	0.0023	0.0023	CcSEcCtD
Cinoxacin—Headache—Vincristine—kidney cancer	0.0023	0.0023	CcSEcCtD
Cinoxacin—Anorexia—Capecitabine—kidney cancer	0.00228	0.00228	CcSEcCtD
Cinoxacin—Vomiting—Gemcitabine—kidney cancer	0.00221	0.00221	CcSEcCtD
Cinoxacin—Rash—Gemcitabine—kidney cancer	0.00219	0.00219	CcSEcCtD
Cinoxacin—Dermatitis—Gemcitabine—kidney cancer	0.00219	0.00219	CcSEcCtD
Cinoxacin—Headache—Gemcitabine—kidney cancer	0.00218	0.00218	CcSEcCtD
Cinoxacin—Nausea—Vincristine—kidney cancer	0.00218	0.00218	CcSEcCtD
Cinoxacin—Insomnia—Capecitabine—kidney cancer	0.00216	0.00216	CcSEcCtD
Cinoxacin—Paraesthesia—Capecitabine—kidney cancer	0.00214	0.00214	CcSEcCtD
Cinoxacin—Hypersensitivity—Paclitaxel—kidney cancer	0.00214	0.00214	CcSEcCtD
Cinoxacin—Decreased appetite—Capecitabine—kidney cancer	0.00208	0.00208	CcSEcCtD
Cinoxacin—Nausea—Gemcitabine—kidney cancer	0.00206	0.00206	CcSEcCtD
Cinoxacin—Pruritus—Paclitaxel—kidney cancer	0.00206	0.00206	CcSEcCtD
Cinoxacin—Erythema multiforme—Doxorubicin—kidney cancer	0.00205	0.00205	CcSEcCtD
Cinoxacin—Pain—Capecitabine—kidney cancer	0.00204	0.00204	CcSEcCtD
Cinoxacin—Tinnitus—Doxorubicin—kidney cancer	0.00202	0.00202	CcSEcCtD
Cinoxacin—Diarrhoea—Paclitaxel—kidney cancer	0.00199	0.00199	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Capecitabine—kidney cancer	0.00195	0.00195	CcSEcCtD
Cinoxacin—Dizziness—Paclitaxel—kidney cancer	0.00192	0.00192	CcSEcCtD
Cinoxacin—Urticaria—Capecitabine—kidney cancer	0.0019	0.0019	CcSEcCtD
Cinoxacin—Abdominal pain—Capecitabine—kidney cancer	0.00189	0.00189	CcSEcCtD
Cinoxacin—Vomiting—Paclitaxel—kidney cancer	0.00185	0.00185	CcSEcCtD
Cinoxacin—Rash—Paclitaxel—kidney cancer	0.00183	0.00183	CcSEcCtD
Cinoxacin—Dermatitis—Paclitaxel—kidney cancer	0.00183	0.00183	CcSEcCtD
Cinoxacin—Headache—Paclitaxel—kidney cancer	0.00182	0.00182	CcSEcCtD
Cinoxacin—Hypersensitivity—Capecitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Cinoxacin—Nausea—Paclitaxel—kidney cancer	0.00173	0.00173	CcSEcCtD
Cinoxacin—Pruritus—Capecitabine—kidney cancer	0.00169	0.00169	CcSEcCtD
Cinoxacin—Diarrhoea—Capecitabine—kidney cancer	0.00163	0.00163	CcSEcCtD
Cinoxacin—Dizziness—Capecitabine—kidney cancer	0.00158	0.00158	CcSEcCtD
Cinoxacin—Oedema—Doxorubicin—kidney cancer	0.00154	0.00154	CcSEcCtD
Cinoxacin—Anaphylactic shock—Doxorubicin—kidney cancer	0.00154	0.00154	CcSEcCtD
Cinoxacin—Vomiting—Capecitabine—kidney cancer	0.00152	0.00152	CcSEcCtD
Cinoxacin—Thrombocytopenia—Doxorubicin—kidney cancer	0.00151	0.00151	CcSEcCtD
Cinoxacin—Rash—Capecitabine—kidney cancer	0.00151	0.00151	CcSEcCtD
Cinoxacin—Dermatitis—Capecitabine—kidney cancer	0.0015	0.0015	CcSEcCtD
Cinoxacin—Headache—Capecitabine—kidney cancer	0.0015	0.0015	CcSEcCtD
Cinoxacin—Anorexia—Doxorubicin—kidney cancer	0.00147	0.00147	CcSEcCtD
Cinoxacin—Nausea—Capecitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Cinoxacin—Insomnia—Doxorubicin—kidney cancer	0.00139	0.00139	CcSEcCtD
Cinoxacin—Paraesthesia—Doxorubicin—kidney cancer	0.00138	0.00138	CcSEcCtD
Cinoxacin—Somnolence—Doxorubicin—kidney cancer	0.00137	0.00137	CcSEcCtD
Cinoxacin—Decreased appetite—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Cinoxacin—Pain—Doxorubicin—kidney cancer	0.00132	0.00132	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00126	0.00126	CcSEcCtD
Cinoxacin—Urticaria—Doxorubicin—kidney cancer	0.00122	0.00122	CcSEcCtD
Cinoxacin—Abdominal pain—Doxorubicin—kidney cancer	0.00122	0.00122	CcSEcCtD
Cinoxacin—Hypersensitivity—Doxorubicin—kidney cancer	0.00113	0.00113	CcSEcCtD
Cinoxacin—Pruritus—Doxorubicin—kidney cancer	0.00109	0.00109	CcSEcCtD
Cinoxacin—Diarrhoea—Doxorubicin—kidney cancer	0.00105	0.00105	CcSEcCtD
Cinoxacin—Dizziness—Doxorubicin—kidney cancer	0.00102	0.00102	CcSEcCtD
Cinoxacin—Vomiting—Doxorubicin—kidney cancer	0.000979	0.000979	CcSEcCtD
Cinoxacin—Rash—Doxorubicin—kidney cancer	0.000971	0.000971	CcSEcCtD
Cinoxacin—Dermatitis—Doxorubicin—kidney cancer	0.00097	0.00097	CcSEcCtD
Cinoxacin—Headache—Doxorubicin—kidney cancer	0.000964	0.000964	CcSEcCtD
Cinoxacin—Nausea—Doxorubicin—kidney cancer	0.000914	0.000914	CcSEcCtD
